Feasibility assessment of radiolabeled FAPI-04 for diagnostic and therapeutic use in rheumatoid arthritis.
Tseng W-Y. et al, (2025), Biomed Pharmacother, 187
Inflammatory disease status and response to TNF blockade are associated with mechanisms of endotoxin tolerance.
Clanchy FI. et al, (2024), J Autoimmun, 148
TNFR2 signalling in inflammatory diseases.
Williams RO. et al, (2024), Best Pract Res Clin Rheumatol
Disease status in human and experimental arthritis, and response to TNF blockade, is associated with MHC class II invariant chain (CD74) isoform expression.
Clanchy FIL. et al, (2022), J Autoimmun, 128
Editorial: Multiple Implications of the Kynurenine Pathway in Inflammatory Diseases: Diagnostic and Therapeutic Applications.
Mándi Y. et al, (2022), Front Immunol, 13
Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression?
Clanchy FIL. et al, (2022), Front Immunol, 13
Modulation of immune cell function, IDO expression and kynurenine production by the quorum sensor 2-heptyl-3-hydroxy-4-quinolone (PQS).
Ogbechi J. et al, (2022), Front Immunol, 13
Standardization of Antigen-Emulsion Preparations for the Induction of Autoimmune Disease Models.
Topping LM. et al, (2022), Front Immunol, 13
Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity.
Kogan NM. et al, (2021), Molecules, 26
Pharmacological modulation of T cell immunity results in long-term remission of autoimmune arthritis
WILLIAMS R. et al, (2021), Proceedings of the National Academy of Sciences of USA
CD200 Limits Monopoiesis and Monocyte Recruitment in Atherosclerosis.
Kassiteridi C. et al, (2021), Circ Res, 129, 280 - 295
Pharmacological modulation of T cell immunity results in long-term remission of autoimmune arthritis.
Huang Y-S. et al, (2021), Proc Natl Acad Sci U S A, 118
TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis.
Clanchy FIL. et al, (2021), J Autoimmun, 118
High-resolution 3D imaging uncovers organ-specific vascular control of tissue aging.
Chen J. et al, (2021), Sci Adv, 7
TNFα inhibitors reduce bone loss in rheumatoid arthritis independent of clinical response by reducing osteoclast precursors and IL-20.
Al-Bogami M. et al, (2020), Rheumatology (Oxford)
Response to: 'Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo et al.
Aungier S. et al, (2020), Ann Rheum Dis, 79
IDO activation, inflammation and musculoskeletal disease.
Ogbechi J. et al, (2020), Exp Gerontol, 131
IDO and Kynurenine Metabolites in Peripheral and CNS Disorders.
Huang Y-S. et al, (2020), Front Immunol, 11